85 results
Page 2 of 5
424B5
a4viset85k37uzgkl
21 Dec 20
Prospectus supplement for primary offering
9:16am
424B3
wfxusx8gqmxp1tc7
11 Dec 20
Prospectus supplement
7:28am
8-K
EX-99.1
66qckder4z8wf0
13 Nov 20
Atossa Therapeutics Announces Third Quarter 2020 Financial Results and Provides Corporate Update
9:30am
8-K
EX-1.1
655w2ad vigs36dz3jdx
25 Sep 20
Entry into a Material Definitive Agreement
5:00pm
424B3
cky2o
25 Sep 20
Prospectus supplement
5:00pm
8-K
EX-1.1
i0yh8rhuyxwpxvl 6mxy
10 Feb 20
Entry into a Material Definitive Agreement
12:00am
424B3
dhn7vevt
7 Feb 20
Prospectus supplement
5:23pm
8-K
jc4n8b8s
17 May 19
Departure of Directors or Certain Officers
4:30pm
8-K
EX-99.2
a18of38xkk jwm899
13 Sep 18
Atossa Genetics Announces Preliminary Results from
12:00am
424B4
wu6jvf0q
10 May 18
Prospectus supplement with pricing info
5:13pm